Brokerages Set Novo Nordisk A/S (NYSE:NVO) PT at $145.25
Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation […]
